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Gliomas are brain tumours that account for more than
50% of the tumours that arise within the central nervous
system. They are highly proliferative, angiogenic, and
develop resistance to the alkylating agents used in che-
motherapy. The median survival time for glioma
patients remains approximately 12-14 months in
patients treated with temozolomide (TMZ) which is
considered the main chemotherapeutic agent. In order
to understand the cellular mechanisms involved in che-
moresistance of glioma cells we analysed the activation
of autophagy in cells treated with TMZ. In addition, we
determined the effect of TMZ in the survival pathways
PI3K/Akt and MAP kinases. For that, U-118 glioma
cells were incubated with different concentrations of
TMZ for different periods of time. Activation of autop-
hagy and of PI3K/Akt and MAP kinase was evaluated by
western blot. Apoptosis was addressed by confocal
microscopy and by flow cytometry. The results indicated
that in glioma cells treated with TMZ there was an
increased expression of LC3 indicated that TMZ acti-
vated autophagy. Glioma cells presented a basal activa-
tion of PI3K/Akt and MAP kinases which was not
blocked by TMZ. TMZ was also unable to induce apop-
tosis in a significant percentage of cells. Together, these
results suggested that chemoresistance of glioma cells to
TMZ is due to TMZ inability to block the activation of
the survival pathways of autophagy, PI3K/Akt and MAP
kinases.
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